FAP and Cachexia: These poor clinical results are potentially explained by recent studies that showed that stromal depletion in murine PDAC models can lead to reduced survival (53–55) and that depletion of FAP-positive cells results in cachexia and anemia due to loss of bone marrow–derived stem cells (56,57).